Prevalence of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae urinary isolates in a tertiary care hospital in Kathmandu, Nepal

BMC Research Notes

Volumn 6, Issue 1, 2013, Pages

  Chander, Anil ^a   Shrestha, Chandrika Devi ^a  

^a KATHMANDU MEDICAL COLLEGE TEACHING HOSPITAL   (Nepal)

Author keywords

Antimicrobial resistance; Escherichia coli; Extended spectrum beta lactamase (ESBL); Klebsiella pneumoniae; Mid stream urine (MSU); Prevalence; Urinary isolates

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE;

BETA LACTAMASE;

ADOLESCENT; ADULT; BIOSYNTHESIS; DRUG EFFECTS; ENZYMOLOGY; ESCHERICHIA COLI; HUMAN; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; NEPAL; TERTIARY CARE CENTER; URINE; YOUNG ADULT;

ADOLESCENT; ADULT; BETA-LACTAMASES; ESCHERICHIA COLI; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEPAL; TERTIARY CARE CENTERS; URINE; YOUNG ADULT;

EID: 84888115559     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-6-487     Document Type: Article

References (41)

1. Antibiotic susceptibility pattern and ESBL prevalence in nosocomial Escherichia coli from urinary tract infections in Pakistan. Ullah F, Malik SA, Ahmed J, Afr J Biotechnol 2009 8 16 3921 3926
2. Nosocomial urinary tract infections. Cox CE, Urol 1988 32 3 210 215 10.1016/0090-4295(88)90386-X 3046098
3. Treatment of urinary tract infection: what's old, what's new, and what works. Gonzalez CM, Schaeffer AJ, World J Urol 1999 17 6 372 382 10.1007/s003450050163 10654368
4. Increasing prevalence of ESBL producing enterobacteriaceae in Europe. Coque TM, Baquero F, Canton R, Eurosurveillance 2008 13 47 1 11
5. Extended spectrum β-lactamases: a clinical update. Paterson DL, Bonomo RA, Clin Microbiol Rev 2005 18 4 657 686 10.1128/CMR.18.4.657-686.2005 16223952 (Pubitemid 41504510)
6. Extended spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Bradford PA, Clin Microbiol Rev 2001 14 4 933 951 10.1128/CMR.14.4.933- 951.2001 11585791 (Pubitemid 32979636)
7. The new beta-lactamases. Jacoby GA, Munoz-Price LS, New Engl J Med 2005 352 4 380 391 10.1056/NEJMra041359 15673804
8. Extended spectrum β-lactamase (ESBL)- producing enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. Rupp ME, Fey PD, Drugs 2003 63 4 353 365 10.2165/00003495-200363040-00002 12558458 (Pubitemid 36259523)
9. Nosocomial outbeak of Klebsiella infection resistant to late-generation cephalosporins. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ, Ann Intern Med 1993 119 353 358 10.7326/0003-4819-119-5-199309010-00001 8135915 (Pubitemid 23310083)
10. Outbreak of ceftazidime resistance due to a novel extended spectrum β-lactamase in isolates from cancer patients. Naumovsky L, Quinn JP, Miyashiro D, Patel M, Bush K, Singer SB, et al. Antimicrob Agents Chemother 1992 36 1991 1996 10.1128/AAC.36.9.1991 1416892
11. Ceftazidime resistant Klebsiella pneumoniae and Escherichia coli blood stream infection: a case control and molecular epidemiologic investigation. Schiappa DA, Hayden MK, Matushek MG, Hashemi FN, Sullivan J, Smith KY, et al. J Infect Dis 1996 174 529 536 10.1093/infdis/174.3.529 8769610 (Pubitemid 26299686)
12. Epidemiology of ciprofloxacin resistance and its relationship to extended spectrum β-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Paterson DL, Mulazimoglu L, Casellas JM, Ko W-C, Goossens H, Gottberg AV, et al. Clin Infect Dis 2000 30 473 478 10.1086/313719 10722430 (Pubitemid 30205291)
13. The Italian ESBL Study Group. Occurrence of extended spectrum β-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to β-lactams and other antimicrobial drugs. Spanu T, Luzzaro F, Perilli M, Amicosante G, Toniolo A, Fadda G, Antimicrob Agents Chemother 2002 46 196 202 10.1128/AAC.46.1.196-202.2002 11751134 (Pubitemid 34031625)
14. Properties of plasmids responsible for production of extended spectrum β-lactamases. Jacoby GA, Sutton L, Antimicrob Agents Chemother 1991 35 164 169 10.1128/AAC.35.1.164 1849707
15. Biochemical sequence analyses of GES-1, a novel class A extended spectrum β-lactamase, and the Class I integrin In52 from Klebsiella pneumoniae. Poirel M, Le Thomas I, Naas T, Karim A, Nordmann P, Antimicrob Agents Chemother 2000 44 622 632 10.1128/AAC.44.3.622-632.2000 10681329 (Pubitemid 30117952)
16. Growing group of extended spectrum β-lactamases: the CTX-M enzymes. Bonnet R, Antimicrob Agents Chemother 2004 48 1 1 14 10.1128/AAC.48.1.1-14.2004 14693512 (Pubitemid 38040170)
17. Extended spectrum β-lactamase-producing organisms. Falagas ME, Karageorgopoulos, J Hosp Infect 2009 73 4 345 354 10.1016/j.jhin.2009.02.021 19596491
18. Antimicrobial susceptibility among organisms from the Asia/ Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. Reinert RR, Low DE, Rossi F, Zhang X, Wattal C, Dowzicky MJ, J Antimicrob Chemother 2007 60 5 1018 1029 10.1093/jac/dkm310 17855724 (Pubitemid 47617749)
19. Prevalence of extended-spectrum β-lactamases in South America. Villegas MV, Kattan JN, Quinteros MG, Casselas JM, Clin Microbiol Infect 2008 14 Suppl. 1 154 158 18154539 (Pubitemid 350269195)
20. SENTRY antimicrobial surveillance program report; Latin America and Brazilian results for 1997 through 2001. Sader HS, Jones RN, Gales AC, Silva JB, Pignatari AC, Braz J Infect Dis 2004 8 1 25 79 10.1590/S1413-86702004000100004 15286878
21. Extended spectrum β-lactamase producing multidrug resistant clinical bacterial isolates at National Public Health Laboratory, Nepal. Poudyal S, Bhatta DR, Shakya G, Upadhyaya B, Dumre SP, Buda G, et al. Nepal Med Coll J 2011 13 1 34 38 21991699
22. Prevalence of extended spectrum beta lactamase (ESBL) production in gram negative isolates from pyogenic infection in tertiary care hospital of Eastern Nepal. Shrestha S, Amatya R, Dutta R, Nepal Med Coll J 2011 13 3 186 189 22808812
23. High prevalence of multidrug resistance in bacterial uropathogens from Kathmandu, Nepal. Baral P, Neupane S, Marasini BP, Ghimire KR, Lekhak B, Shrestha B, BMC Res Notes 2012 5 38 10.1186/1756-0500-5-38 22260454
24. Tests for identification of bacteria. Collee JG, Miles RS, Watt B, Mackie and McCartney Practical Medical Microbiology New York: Churchill Livingstone, Collee JG, Fraser AG, Marmion BP, Simmons A, 14 1996 131 149
25. Clinical Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing; Twenty First informational supplement (M 100-S21) Wayne PA: Clinical and Laboratory Standards Institute 2011
26. Hospital and community isolates of uropathogens at a tertiary hospital in South Africa. Habte TM, Dube S, Ismail N, Hoosen AA, S Afr Med J 2009 99 584 587 19908617
27. Resistance of uropathogens in symptomatic urinary tract infections in Leon, Nicaragua. Matute AJ, Hak E, Schurink CAM, McArthur A, Alonso E, Pantagua M, et al. Int J Antimicrob Agents 2004 23 506 509 10.1016/j.ijantimicag.2003.10. 003 15120732 (Pubitemid 38569602)
28. Antibacterial susceptibility of some urinary tract pathogens to commonly used antibiotics. Tambekar DH, Dhanorkar DV, Gulhane DR, Khanadelwal VK, Dudhane MN, Afr J Biotechnol 2006 5 1562 1565 (Pubitemid 44413376)
29. Detection and typing of extended- spectrum β-lactamases in clinical isolates of the family Enterobacteriaceae in a medical center in Turkey. Durmaz R, Durmaz B, Koroglu M, Tekerekoglu MS, Microb Drug Resist 2001 7 171 175 10.1089/10766290152045048 11442343 (Pubitemid 32578739)
30. Extended spectrum lactamase in urinary isolates of E.coli and Klebsiella pneumoniae-prevalence and susceptibility patterns in a tertiary care hospital. Babypadmini S, Appalaraju B, Indian J Med Microbiol 2004 22 172 174 17642726 (Pubitemid 39206740)
31. Bacteriuria by extended spectrum beta-lactamase producing E.coli and Klebsiella pneumoniae isolates in a government hospital in south of Tehran, Iran. Aminzadeh Z, Sadat KM, Sha'bani M, Iran J Kidney Dis 2008 2 197 200 19377237
32. Urinary tract infections-an overview on the prevalence and the anti-biogram of gram negative uropathogens in a tertiary care center in North Kerala, India. Ahmed SM, Jakribettu RP, Koyakutty S, Arya B, Shakir VPA, J Clin Diagn Res 2012 6 1192 1195
33. Urinary tract infections in a rural community of Nigeria. Oladeinde BH, Omoregie R, Olley M, Anunibe JE, North Amer J Med Sci 2011 3 75 77
34. Antibiotic resistance patterns in uropathogens at a tertiary care hospital at Jhalawar with special reference to ESBL, AmpC b-lactamase and MRSA production. Dalela G, Gupta S, Jain DK, Mehta P, J Clin Diagn Res 2012 6 4 645 651
35. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar. Randrianirina F, Soares J-L, Carod J-F, Ratsima E, Thonnier V, Combe P, et al. J Antimicrob Chemother 2007 59 309 312 17138569 (Pubitemid 47072073)
36. Frequency of extended spectrum beta-lactamase (ESBLs) producing Escherichia coli and Klebsiella pneumoniae isolated from urine in an Iranian 1000-bed tertiary care hospital. Behrooozi A, Rahbar M, Yousefi JV, Afr J Microbiol Res 2010 4 9 881 884
37. High prevalence of extended spectrum β-lactamase producing pathogens: results of a surveillance study in two hospitals in Ujjain, India. Pathak A, Marothi Y, Kekre V, Mahadik K, Macaden R, Lundborg CS, Infect Drug Resist 2012 5 65 73 22570555
38. Antibiogram of extended spectrum beta-lactamase (ESBLs) producing Escherichia coli and Klebsiella pneumoniae isolated from hospital samples. Alipourfard I, Nili NY, Bangladesh J Med Microbiol 2010 4 1 32 36
39. Antimicrobial resistance and spread of multi drug resistant Escherichia coli isolates collected from nine urology services in the Euregion Meuse-Rhine. van der Donk CFM, van de Bovenkamp JHB, De Brauwer EIGB, De Mol P, Feldhoff K-H, Kalka-Moll WM, et al. PLoS One 2012 7 10 47707 10.1371/journal.pone.0047707 23082197
40. Current efficacy of antibiotics against Klebsiella isolates from urine samples-a multi-centric experience in Karachi. Abdullah FE, Mushtaq A, Irshad M, Rauf H, Afzal N, Rasheed A, Pak J Pharm Sci 2013 26 1 11 15 23261722
41. Aminoglycosides: a practical review. Gonzalez LS, Spencer JP, Am Fam Physician 1998 58 8 1811 1820 9835856 (Pubitemid 28536702)